» Articles » PMID: 17305510

Osteoarthritis: Aging of Matrix and Cells--going for a Remedy

Overview
Specialty Pharmacology
Date 2007 Feb 20
PMID 17305510
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

It has been known for a very long time that aging is the most prominent risk factor for the initiation and progression of osteoarthritis. This might be related to continuous mechanical wear and tear and/or result from time/age-related modifications of cartilage matrix components. Also a mere loss of viable cells over time, due to apoptosis or any other mechanism, might contribute. More recent evidence, however, supports that stressful conditions for the cells might promote chondrocyte senescence and might be in particular important for the progression of the osteoarthritic disease process. One of the most important implications of this hypothesis is that it points to issues of cellular degeneration as the basis for understanding of the initiation and the progression of osteoarthritis. Equally important, it emphasizes that whatever treatment we envisage for osteoarthritis, we must take into account that we are dealing with aged/(pre)senescent cells which no longer have the abilities of their juvenile counterparts to respond to the many mechanical, inflammatory, and traumatic assaults to the tissue. Thirdly, this directs treatment options to deal with the senescence of cells, which are only conceptually available today. Clearly, if accumulation of wear and tear over time is the major scenario of osteoarthritis, any therapy will largely be hopeless as moving and loading the joints is unavoidable as implication of their use. However, this review intends to open up the idea that age-related changes are less a fate, but rather a challenge for therapeutic intervention which can be taken.

Citing Articles

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy.

Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C Signal Transduct Target Ther. 2024; 9(1):234.

PMID: 39289339 PMC: 11408715. DOI: 10.1038/s41392-024-01931-z.


Metformin regulates chondrocyte senescence and proliferation through microRNA-34a/SIRT1 pathway in osteoarthritis.

Yan S, Dong W, Li Z, Wei J, Han T, Wang J J Orthop Surg Res. 2023; 18(1):198.

PMID: 36915137 PMC: 10012483. DOI: 10.1186/s13018-023-03571-5.


Liver X Receptor activation regulates genes involved in lipid homeostasis in developing chondrocytes.

Sun M, Beier F Osteoarthr Cartil Open. 2022; 2(1):100030.

PMID: 36474558 PMC: 9718240. DOI: 10.1016/j.ocarto.2020.100030.


mtDNA variability determines spontaneous joint aging damage in a conplastic mouse model.

Scotece M, Vaamonde-Garcia C, Lechuga-Vieco A, Cortes A, Gomez M, Filgueira-Fernandez P Aging (Albany NY). 2022; 14(15):5966-5983.

PMID: 35779570 PMC: 9417242. DOI: 10.18632/aging.204153.


Morphology of the acromioclavicular-joint score (MAC).

Farkhondeh Fal M, Junker M, Mader K, Frosch K, Kircher J Arch Orthop Trauma Surg. 2022; 143(3):1523-1529.

PMID: 35381874 PMC: 9957884. DOI: 10.1007/s00402-022-04407-3.